Health programs impacting MDMA. Issues related to medical devices. Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to Medical Device User Fee Amendments (MDUFA) implementation. Issues related to physician fee schedule. Issues related to coverage of telehealth services. Issues related to regulation and reimbursement of artificial intelligence in healthcare. Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC). Supply chain issues. Cyber security issues related to consumer and health data privacy. TCET Issues related to the New Technology Add on Payment (NTAP).
Literal federal measure citations: H.R. 1691